Besson C. It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies. haematol [Internet]. 2022Mar.1 [cited 2025Dec.22];107(3):572-3. Available from: https://haematologica.org/article/view/haematol.2021.279457